Lataa...
Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment
IMPORTANCE: The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated the benefit of lowering systolic blood pressure (SBP) to 120 mm Hg, yet other trials, such as Heart Outcomes Prevention Evaluation–3 (HOPE-3), did not find consistent benefit. How to incorporate these results into the t...
Tallennettuna:
| Julkaisussa: | JAMA Cardiol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5549553/ https://ncbi.nlm.nih.gov/pubmed/27604060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2016.2861 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|